Given the pronounced expression of PROS1 and AXL compared to CCL15 and CCR1 in HCC (Figure 4d), we proceeded to focus on investigating the PROS1-AXL pathway for experimental validation. The gene discussed is PROS1; the disease is hepatocellular carcinoma.